Sinuses that stay inflamed for 12 weeks or longer qualify as chronic rhinosinusitis, a condition affecting roughly 12% of adults. Unlike a cold or short-lived sinus infection that clears up on its own, chronic sinus inflammation persists because something keeps triggering or sustaining the immune response in your nasal passages. The cause is rarely a single factor. It’s usually a combination of structural, immune, microbial, and environmental forces working together.
What Counts as Chronic Sinus Inflammation
Doctors define chronic rhinosinusitis as at least 12 continuous weeks of two or more key symptoms: thick or discolored drainage (from the front of the nose or dripping down the throat), nasal congestion, facial pain or pressure, and a reduced sense of smell. If your sinuses have been bothering you for a few weeks after a cold, that’s still acute sinusitis. The 12-week mark is where the diagnosis shifts, and so does the approach to treatment, because the underlying problem is no longer a simple infection but ongoing inflammation of the sinus lining itself.
Your Immune System Is Overreacting
In chronic sinusitis, the sinus lining becomes packed with immune cells that don’t stand down the way they should. Research shows that T cells, which coordinate immune responses, are significantly elevated in inflamed sinus tissue compared to healthy tissue. So are macrophages, the cells responsible for engulfing invaders, and B cells, which produce antibodies. All of these stay activated, keeping the tissue swollen and irritated even when there’s no active infection to fight.
There are different flavors of this overreaction. In one common type, the immune system leans heavily on a particular inflammatory pathway that attracts eosinophils, a type of white blood cell linked to allergies and asthma. This version often comes with nasal polyps, which are soft, painless growths that dangle from the sinus lining. In another type, neutrophils (a different white blood cell) dominate, and the inflammation pattern looks more like what you’d see with a chronic bacterial presence. The type matters because it shapes which treatments work best.
Bacteria That Antibiotics Can’t Fully Reach
One major reason sinus inflammation keeps coming back is bacterial biofilms. These are colonies of bacteria that anchor themselves to the sinus lining and surround themselves with a protective matrix, almost like a biological shield. Between 44% and 92% of chronic sinusitis patients have biofilms present in their sinuses, depending on the detection method used.
Biofilms are dramatically harder to kill than the same bacteria floating freely in mucus. Common antibiotics like amoxicillin and clarithromycin lose effectiveness against biofilm-embedded bacteria because the drugs struggle to penetrate the matrix, the bacteria inside slow their metabolism (making them less vulnerable), and the colony activates genetic defense mechanisms that pump the antibiotic back out. About 20% of bacteria that test as antibiotic-susceptible in a standard lab culture can still form resistant biofilms. This is why you might feel better during a course of antibiotics, only to have symptoms return weeks later. The biofilm survives, re-seeds the sinus lining, and the cycle restarts.
Structural Problems That Trap Mucus
Your sinuses drain through narrow openings called ostia. Anything that narrows or blocks those openings traps mucus inside, creating a warm, stagnant environment where bacteria thrive and inflammation worsens. A deviated septum, where the wall between your nasal passages is crooked, is one of the most common structural culprits. Nasal polyps are another. When polyps grow large enough, they physically obstruct the passages, leading to repeated infections, difficulty breathing, worsened asthma attacks, and even sleep disruption. Some people also have naturally narrow drainage pathways that become problematic only when combined with mild swelling from allergies or irritants.
Environmental Triggers You May Not Suspect
Air pollution plays a larger role in chronic sinus problems than most people realize. Fine particulate matter (PM2.5, the tiny particles from vehicle exhaust, wildfire smoke, and industrial emissions) is significantly associated with chronic sinusitis diagnosis. One study found that for every unit increase in PM2.5 concentration, the risk of needing repeat sinus surgery rose by 89%. PM10, a slightly larger particle, showed a 22% increase in sinusitis prevalence per unit increase in exposure.
Particulate matter doesn’t just irritate the lining directly. It also disrupts the balance of bacteria living in your nasal passages. Higher PM2.5 levels are linked to lower populations of Corynebacterium, a beneficial bacterium in the nasal microbiome. When protective bacteria decline, harmful species can gain a foothold more easily. If you live near a busy road, in a city with poor air quality, or in a wildfire-prone region, chronic pollution exposure could be a significant and underappreciated contributor to your sinus problems.
Indoor irritants matter too. Cigarette smoke, strong cleaning products, and dry heated air in winter all contribute to ongoing nasal irritation that keeps the inflammatory cycle going.
Acid Reflux and Sinus Inflammation
Gastric acid that travels up from the stomach can reach the back of the throat and, in some cases, the nasal passages. This is called laryngopharyngeal reflux, and it works through at least two pathways. The first is direct contact: acid hitting the nasal and nasopharyngeal lining damages the mucosa, impairs the tiny cilia that sweep mucus out of the sinuses, and promotes blockage and infection. Changes in pH are known to alter both the movement and physical structure of these cilia.
The second pathway is indirect. Acid in the lower esophagus triggers the vagus nerve, which can reflexively cause the nasal lining to swell, increase mucus production, and reduce airflow, even without acid ever reaching the nose. In experiments with healthy volunteers, infusing acid into the lower esophagus alone was enough to increase nasal symptoms and measurably reduce nasal airflow. If you have frequent heartburn, a sour taste in the morning, or throat clearing alongside your sinus problems, reflux may be part of the picture.
Nasal Steroid Sprays Are the First-Line Treatment
Daily nasal corticosteroid sprays are the most effective non-surgical treatment for chronic sinus inflammation. In clinical trials, 76% of patients using a prescription nasal steroid reported meaningful improvement after 12 weeks, compared to just 27% of those using a placebo. These sprays work by dialing down the immune overreaction directly at the sinus lining, reducing swelling, shrinking polyps, and restoring drainage. They take days to weeks to reach full effect, so consistency matters more than any single dose.
Saline nasal irrigation, using a squeeze bottle or neti pot, is a simple add-on that helps flush out mucus, allergens, and irritants. Twice-daily rinsing is a common recommendation, though the ideal frequency hasn’t been established by rigorous studies. Isotonic saline (the same salt concentration as your body) is generally preferred over hypertonic (saltier) solutions because it causes less stinging and discomfort, with mixed evidence on whether the saltier version offers any extra benefit.
When Surgery Becomes the Next Step
Functional endoscopic sinus surgery opens up the blocked drainage pathways by removing polyps, diseased tissue, and any bone obstructing the natural sinus openings. At roughly 18 months after surgery, 97.5% of patients in one long-term study reported improvement, with 85% describing it as marked improvement. Even at nearly 8 years out, 98.4% still reported being better than before surgery. The tradeoff: about 18% of patients needed a second procedure over that same timeframe, usually because polyps regrew or scar tissue formed.
Biologic Medications for Severe Cases
For people with nasal polyps who don’t respond well to steroids or keep relapsing after surgery, injectable biologic medications represent a newer option. These drugs block specific immune signaling molecules that drive the type of inflammation responsible for polyp growth. In one 52-week trial, polyp scores shrank significantly in patients receiving a biologic, while polyps in the placebo group continued to grow. Another analysis showed the proportion of patients with moderate-to-severe disease dropped from 86% to 21% with biologic treatment, compared to virtually no change with placebo. Quality-of-life scores also improved substantially. These medications are typically reserved for the most persistent cases because they require ongoing injections and are expensive, but for the right patient, the results can be dramatic.